Stay up to date with the latest developments in therapeutics by reading the world’s most respected source of authoritative drug information. For over 40 years Drugs has been the definitive journal of drugs and therapeutics, providing independent and crucial information authored by leading international clinicians and researchers.
Our prestigious and truly international Honorary Editorial Board ensures content of the highest quality to support clinical decision-making.
Through a rigorous and comprehensive program of peer-reviewed evaluations, Drugs provides detailed and objective analysis covering the full spectrum of new and established drug therapies in all disease areas.
Erratum to: Cariprazine: First Global Approval
Paul L. McCormack (March 2016)
AdisInsight ReportTopical Collection Topical Collection on Immuno-Oncology
Elotuzumab: First Global Approval
Anthony Markham (March 2016)
Selexipag: First Global Approval
Lesley J. Scott (March 2016)
- Impact Factor 4.343
- Available 1971 - 2016
- Volumes 76
- Issues 766
- Articles 7,859
- Open Access 49 Articles
Stay up to Date
Find a Volume or Issue
- Journal Title
- Volume 1 / 1971 - Volume 76 / 2016
- Print ISSN
- Online ISSN
- Springer International Publishing
- Additional Links
- Industry Sectors
To view the rest of this content please follow the download PDF link above.